🔥🐔 BizChicken 🐔🔥
Companies Similar to Annovis Bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
AEON Biopharma, Inc.
ABP-450
AEON Biopharma, Inc. is a biopharmaceutical company focused on developing botulinum toxins for treating debilitating medical conditions. The company also develops ABP-450 for migraines, cervical dystonia, and gastroparesis.
Symbol: AEON
Recent Price: $0.56
Industry: Biotechnology
CEO: Mr. Marc Forth
Sector: Healthcare
Employees: 5
Address: 4040 Macarthur Boulevard, Newport Beach, CA 92614
Phone: 949-354-6499
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Anebulo Pharmaceuticals, Inc.
ANEB-001
Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.
Symbol: ANEB
Recent Price: $1.64
Industry: Biotechnology
CEO: Mr. Richard Anthony Cunningham
Sector: Healthcare
Employees: 2
Address: 1415 Ranch Road 620 South, Lakeway, TX 78734
Phone: 512 598 0931
Last updated: 2024-12-31
Annexon, Inc.
ANX005
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. It develops several investigational monoclonal antibodies targeting distinct disease processes.
Symbol: ANNX
Recent Price: $5.13
Industry: Biotechnology
CEO: Mr. Douglas Love Esq., J.D.
Sector: Healthcare
Employees: 71
Address: 1400 Sierra Point Parkway, Brisbane, CA 94005
Phone: 650 822 5500
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
BioVie Inc.
BIV201, NE3107
Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.
Symbol: BIVI
Recent Price: $2.09
Industry: Biotechnology
CEO: Mr. Cuong Viet Do M.B.A.
Sector: Healthcare
Employees: 14
Address: 680 West Nye Lane, Carson City, NV 89703
Phone: 775 888 3162
Last updated: 2024-12-31
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
Moleculin Biotech, Inc.
Annamycin
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing drug candidates for highly resistant tumors and viruses. Its lead product, Annamycin, is in Phase 1/2 studies, and it also works on other candidates targeting brain tumors, pancreatic cancer, and COVID-19.
Symbol: MBRX
Recent Price: $1.79
Industry: Biotechnology
CEO: Mr. Walter V. Klemp
Sector: Healthcare
Employees: 18
Address: 5300 Memorial Drive, Houston, TX 77007
Phone: 713 300 5160
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Synaptogenix, Inc.
Bryostatin-1
Synaptogenix, Inc. is a biopharmaceutical company focused on developing drug candidates for neurodegenerative diseases, including Alzheimer's disease, using Bryostatin-1.
Symbol: SNPX
Recent Price: $3.37
Industry: Biotechnology
CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)
Sector: Healthcare
Employees: 5
Address: 1185 Avenue of the Americas, New York, NY 10036
Phone: 973 242 0005
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Annovis Bio, Inc.
Buntanetap
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.
Symbol: ANVS
Recent Price: $5.08
Industry: Biotechnology
CEO: Dr. Maria L. Maccecchini Ph.D.
Sector: Healthcare
Employees: 6
Address: 1055 Westlakes Drive, Berwyn, PA 19312
Phone: 610 727 3913
Last updated: 2024-12-31
AN2 Therapeutics, Inc.
epetraborole
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases, including epetraborole for non-tuberculous mycobacterial lung disease.
About | About | Contact | Contact | Careers | Careers | Careers | About | Vision/Values | Jobs | Vision/Values | Benefits | Jobs | Benefits
Symbol: ANTX
Recent Price: $1.41
Industry: Biotechnology
CEO: Mr. Eric E. Easom
Sector: Healthcare
Employees: 41
Address: 1800 El Camino Real, Menlo Park, CA 94027
Phone: 650-331-9090
Last updated: 2024-12-31
Enanta Pharmaceuticals, Inc.
N/A
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.
About | Leadership | Directors | Contact | Careers | Careers | Culture | About | About | About
Symbol: ENTA
Recent Price: $5.85
Industry: Biotechnology
CEO: Dr. Jay R. Luly Ph.D.
Sector: Healthcare
Employees: 145
Address: 500 Arsenal Street, Watertown, MA 02472
Phone: 617 607 0800
Leadership
- Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
- Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
- Matthew P. Kowalsky, J.D., Chief Legal Officer
- Brendan Luu, Chief Business Officer
- Paul J. Mellett, Chief Financial and Administrative Officer
- Yat Sun Or, Ph.D., Chief Scientific Officer
- Scott T. Rottinghaus, M.D., Chief Medical Officer
- Bruce L.A. Carter, Ph.D., Chairman of the Board
- Mark G. Foletta, Board Member
- Yujiro S. Hata, Board Member
- Kristine Peterson, Board Member
- Lesley Russell, MBChB, MRCPb, Board Member
- Terry Vance, Board Member
Last updated: 2024-12-31
Denali Therapeutics Inc.
BIIB122/DNL151
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutic candidates for neurodegenerative diseases. Its pipeline includes treatments for Parkinson's disease, hunter syndrome, ALS, multiple sclerosis, and Alzheimer's disease. It collaborates with companies such as Takeda Pharmaceutical Company and Genentech, Inc.
Symbol: DNLI
Recent Price: $20.24
Industry: Biotechnology
CEO: Dr. Ryan J. Watts Ph.D.
Sector: Healthcare
Employees: 364
Address: 161 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 866 8548
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31